Hypoxia-Ischemia, Brain Clinical Trial
Official title:
Safety, Tolerability and Neurophysiological Response of Transauricular Vagus Nerve Stimulation in Children Without Brain Injury
Verified date | December 2023 |
Source | Washington University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to learn about brain waves during transauricular vagus nerve stimulation (taVNS) in healthy children. The main questions it aims to answer are: - What is the safety, tolerability, and physiological response of taVNS in children? - Does the electroencephalogram (EEG) change during taVNS? Participants will - undergo a brief titration session where taVNS will be titrated to below perceptual threshold - receive one session of 30 minutes of taVNS - undergo clinical EEG monitoring during taVNS - Continuous cardiorespiratory monitoring via pulse oximetry and blood pressure every 5 minutes - Answer tolerability questions before, during and after 30 minute taVNS session
Status | Enrolling by invitation |
Enrollment | 10 |
Est. completion date | November 15, 2025 |
Est. primary completion date | November 15, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 18 Years |
Eligibility | Inclusion Criteria: - Admitted for clinical EEG for spell characterization at investigator's institution Exclusion Criteria: - known history of brain injury - known history of bradycardia - congenital heart disease - pregnant - pacemaker or wearable defibrillator - undergoing active cancer treatment |
Country | Name | City | State |
---|---|---|---|
United States | Washington University in St. Louis | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety: Heart rate | Determined by continuous pulse oximeter. If heart rate drops below 60 beats per minute (bpm) in children younger than 9 years and below 50 bpm in children older than 9 years for more than 30 seconds, the stimulation will be stopped. | Baseline and continuously for 30 minutes during study visit. It will be recorded and assessed every 5 minutes during 30 minute study visit. | |
Primary | Safety: Oxygen saturation | Determined by continuous pulse oximeter. If oxygen saturation drops below 92% for more than 30 seconds, stimulation will stop. | Baseline and continuously for 30 minutes during study visit. It will be recorded and assessed every 5 minutes during 30 minute study visit. | |
Primary | Tolerability: Face, Legs, Activity, Cry, Consolability (FLACC) | Observation pain assessment before, during and after stimulation. FLACC scale is a 0-10 pain scale with 10 being severe pain and 0 being no pain. | Baseline prior to stimulation, 15 minutes into the stimulation and immediately following the 30 minute stimulation. | |
Primary | Tolerability: Tolerance Questionnaire | Qualitative survey of side effects, ranking of preference of taVNS activity and 6-point comfort scale (6 being severely uncomfortable). Completed before, during and after stimulation | Baseline prior to stimulation, 15 minutes into the stimulation and immediately following the 30 minute stimulation. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01192776 -
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A | |
Completed |
NCT01092637 -
The TOBY Children Study
|
N/A | |
Completed |
NCT00006516 -
Home Stimulation for Brain-Asphyxiated Infants
|
Phase 2 | |
Recruiting |
NCT05390060 -
Delineating Between Pathophysiologic Phenotypes of Hypoxic Ischemic Brain Injury After Cardiac Arrest
|
N/A | |
Completed |
NCT02605733 -
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
|
||
Completed |
NCT00375908 -
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
|
N/A | |
Completed |
NCT00005772 -
Whole-Body Cooling for Birth Asphyxia in Term Infants
|
Phase 3 | |
Completed |
NCT02991976 -
Oxygen Concentration and Recovery After Carotid Endarterectomy
|
N/A | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Completed |
NCT03112486 -
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
|
||
Completed |
NCT01793129 -
Preemie Hypothermia for Neonatal Encephalopathy
|
N/A | |
Recruiting |
NCT04217551 -
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
|
N/A | |
Completed |
NCT04261335 -
The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy
|
Phase 1 | |
Not yet recruiting |
NCT05514665 -
Functional Imaging of Baby Brains
|
||
Recruiting |
NCT06048796 -
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
|
N/A | |
Completed |
NCT03543371 -
Neuropsychological Outcome After Cardiac Arrest
|
||
Not yet recruiting |
NCT06139250 -
Development of a High-speed Multimodal Photoacoustic/Ultrasound System for Functional Imaging of the Neonatal Brain
|
||
Recruiting |
NCT04198792 -
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
|
||
Completed |
NCT01483495 -
Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study
|
||
Completed |
NCT03941015 -
Tissue Oxygenation During Treatment of Infant Congenital Heart Defects
|